BEGIN:VCALENDAR VERSION:2.0 PRODID:-//BioNJ - ECPv6.15.20//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:BioNJ X-ORIGINAL-URL:https://bionj.org X-WR-CALDESC:Events for BioNJ REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20220313T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20221106T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20230312T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20231105T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20240310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20241103T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20260308T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20261101T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20250626T120000 DTEND;TZID=America/New_York:20250626T133000 DTSTAMP:20260503T074134 CREATED:20250516T151725Z LAST-MODIFIED:20250612T175036Z UID:15566-1750939200-1750944600@bionj.org SUMMARY:Clinical Development Webinar DESCRIPTION:Master Protocols in Clinical Trials: Driving Innovation\, Efficiency & Patient-Centric Research \n\n\n\nThursday\, June 26 | 12:00 p.m.-1:30 p.m. | Webinar \n\n\n\n\nRegister Today for Free!\n\n\n\n\n\n\nMaster Protocols in Clinical Trials \n\n\n\n“Master protocols are innovative clinical trials designed with multiple sub-studies\, subgroup-populations\, and subprotocols. They aim to explore or evaluate multiple therapies or multiple subpopulations in parallel under a single overarching protocol\, with the characteristics of improving efficiency and establishing uniformity through standardization of procedures in clinical trials. Master protocols could help address scientific\, operational\, and competitive challenges in the existing drug development model.” ~AppliedClincialTrialsOnline.Com \n\n\n\n\n\nJoin us for an insightful FREE webinar exploring how Master Protocols are transforming the clinical trial landscape. Designed to increase efficiency and flexibility\, Master Protocols offer a unified approach to studying multiple therapies\, diseases or Patient subgroups under a single overarching framework. \n\n\n\nIn this session\, you’ll:  \n\n\n\n\nGain efficiency with Master Protocol\n\nOptimize resource allocation\n\n\n\nStreamline trial execution\n\n\n\n\n\nAccelerate drug development\n\nExpand quickly across indications\n\n\n\nSupport multiple launches \n\n\n\n\n\nEnhance Patient journey\n\nEncourage sub-studies within the same trial to assess variations of Patient treatment options\n\n\n\nBalancing innovation around validity and relevance with Patient-centered approaches\n\n\n\n\n\n\nLearning objectives include:  \n\n\n\n\nDefine the Master Protocol in drug development\n\n\n\nOutline key elements of a successful Master Protocol\n\n\n\nArticulate the regulatory considerations related to the FDA Guidance on Master Protocols\n\n\n\nAdapt the Master Protocol design for oncology to other therapeutic areas\n\n\n\n\nWhether you’re a clinical operations professional\, researcher or sponsor\, this webinar will equip you with strategic insights to drive innovation while keeping Patients at the center of trial design. \n\n\n\nSpeakers \n\n\n\n\nLincy George\, PharmD\, Vice President\, Global Regulatory Affairs\, Oncology\, Specialty Care Business Unit\, Sanofi  \n\n\n\nDr. George is a seasoned regulatory affairs professional with more than 20 years’ experience in large global pharmaceutical companies securing drug approvals for several high priority brands. She has broad cross functional experience with diverse teams in both development and commercial organizations\, working on launch brands as well as products in development. \n\n\n\n\n\n\n\n\n\nBradley Smith\, Ph.D.\, Vice President\, Translational Medicine\, IQVIA  \n\n\n\nDr. Smith is a recognized leader in biomarker and companion diagnostic development\, bringing deep experience across laboratory research\, clinical implementation and Patient care. He is a subject matter expert in drug and diagnostic strategy\, leading commercial planning and the integration of companion diagnostics in oncology and other therapeutic areas. His responsibilities include regulatory\, technical and scientific oversight ― including U.S. registration. \n\n\n\n\n\n\n\n\n\nKatherine Sugarman\, M.D.\, Senior Vice President\, Clinical Development Strategy\, Genmab \n\n\n\nDr. Sugarman possesses a wealth of experience and expertise in oncology clinical development\, both from academia and the pharmaceutical industry. As part of Genmab’s ongoing evolution in R&D\, Dr. Sugarman oversees the clinical development strategy of their pipeline\, ensuring strategic trial design\, and providing scientific\, medical and statistical analysis insights for the interpretation of clinical data to drive promising molecules forward to address high unmet medical needs for Patients.​  \n\n\n\n\n\n\n\n\n\nModerator: Prasad Subramaniam\, Ph.D\, PMP\, sMBA\, Associate Director\, Portfolio & Program Management\, Genmab \n\n\n\nDr. Subramaniam is currently Associate Director within the Development Program Management function at Genmab\, supporting late-stage oncology and hematology programs. He is an experienced drug development leader with over 12 years of combined academic and industry experience spanning program and stakeholder management\, product development and strategic insights and competitive intelligence across hematology\, immuno-oncology and solid tumors. \n\n\n\n\n\n\n\n\n\nChris Pullion\, DO\, Medical Director\, Soligenix \n\n\n\nDr. Pullion oversees Soligenix’s study protocol design and implementation\, safety and pharmacovigilance; assists with clinical operations and regulatory interactions; and reviews all study related reports\, assessments and data analysis. He has been the clinical lead on numerous research programs over the years\, including most recently Soligenix’ two Phase 3 studies where he oversaw everything from protocol design and conception through to drafting clinical study reports and preparation for new drug applications. \n\n\n\n\nDon’t miss this opportunity to advance your understanding of the future of clinical trials. Click here to register for free and join us on June 26! URL:https://bionj.org/event/clinical-development-webinar/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2025/05/Clinical-Development-Webinar.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250605T083000 DTEND;TZID=America/New_York:20250605T150000 DTSTAMP:20260503T074134 CREATED:20250408T161423Z LAST-MODIFIED:20250514T175355Z UID:15296-1749112200-1749135600@bionj.org SUMMARY:2025 BioNJ HR Conference DESCRIPTION:Adapt & Advance Amidst Ambiguity…Again \n\n\n\nThursday\, June 5\, 2025 | 8:30 a.m.-3:00 p.m. \n\n\n\nKean University | North Avenue Academic Building | 1000 Morris Ave.\, Union\, NJ \n\n\n\n\n\nBioNJ is recognized by SHRM to offer Professional Development Credits (PDCs) for SHRM-CP® or SHRM-SCP® recertification activities. This program is approved for 4 SHRM credits. \n\n\n\n\n\nRegistration is now open for BioNJ’s 12th Annual HR Conference taking place at Kean University on June 5. Come ready to connect with other life sciences HR professionals\, learn from industry experts on issues affecting your organization and leave with best practices that will enable you to position your company and your employees for success.  \n\n\n\nJoin the BioNJ HR community for answers\, insights and a chance to contribute. Knowledge is power and collaboration is crucial in creating new opportunities and growing the ecosystem. \n\n\n\n\nRegister Today\n\n\n\nBecome a Sponsor\n\n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nCome ready to gather new and creative ideas\, strategies and tactics for how to navigate today’s HR challenges and opportunities in the life sciences sector.  \n\n\n\nClick here to register now. Registration is $195 for BioNJ Members and $295 for Future Members. To learn about Sponsorship opportunities\, contact Cheri Hennessy at CHennessy@BioNJ.org or 609-890-3185.  \n\n\n\n\n\n\n\n\n\n\nDownload Kean Campus Map URL:https://bionj.org/event/2025-bionj-hr-conference/ LOCATION:Kean University\, 1000 Morris Ave\, Union\, New Jersey\, 07083\, United States CATEGORIES:BioNJ Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250520T120000 DTEND;TZID=America/New_York:20250520T133000 DTSTAMP:20260503T074134 CREATED:20250408T154916Z LAST-MODIFIED:20250515T170621Z UID:15276-1747742400-1747747800@bionj.org SUMMARY:2025 BioNJ Legal Compliance & Regulatory Forum Webinar DESCRIPTION:AI for Legal\, Regulatory & Compliance Professionals \n\n\n\nTuesday\, May 20 | 12:00 p.m.-1:30 p.m. | Webinar \n\n\n\n\nRegister Today for Free!\n\n\n\n\nPlease join us for a robust conversation focused on demystifying AI\, with insight from academia\, as well as legal and technology experts.  \n\n\n\nThe panel will: \n\n\n\n\nProvide a basic understanding for executives of ‘What is AI?’\n\n\n\nDistinguish AI from data analytics from an education and technology perspective\n\n\n\nDiscuss AI and data analytics expectations as included in the September 2024 U.S. DOJ Evaluation of Corporate Compliance Programs (ECCP) update and General Compliance Program Guidance (GCPG)\n\n\n\nProvide examples of ‘where to start’\, how biopharma companies have begun to utilize AI tools and what may be on the horizon\n\n\n\nDiscuss how agencies\, such as the Department of Justice\, FDA and Veterans Affairs have begun to deploy AI tools\n\n\n\nShare best practices for identifying and managing risks \n\n\n\nOutline anticipated changes to regulations and expectations with the Trump Administration\n\n\n\n\nPanelists: \n\n\n\n\n\n\n\n\n\nRachel BatykeferVice PresidentCIA & Compliance OperationsMallinckrodt Pharmaceuticals \n\n\n\n\n\n\n\n\n\nJacob Elberg\, J.D.Professor of LawFaculty Director\, Center for Health & Pharma LawSeton Hall University School of Law \n\n\n\n\n\n\n\n\n\nJeremy OsinskiPrincipalForensic & Integrity ServicesErnst & Young  \n\n\n\n\n\n\n\n\n\nAdam Solander\, J.D.PartnerKing & Spalding \n\n\n\n\n\n\n\n\n\nModeratorLisa Dwyer\, J.D.PartnerKing & Spalding \n\n\n\n\n\nJoin us virtually for this important conversation on May 20. Registration is open and free! \n\n\n\nBioNJ has a new Membership Database. When registering\, you will need to start by clicking “Create Account”. If you have an account\, you may be prompted to reset your password. If you do not have an account\, you’ll need to create one. If you need assistance\, please call 609-890-3185. Thank you. URL:https://bionj.org/event/2025-bionj-legal-compliance-regulatory-forum-webinar/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2025/01/BioNJ-Logo_CMYK_2017.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250306T120000 DTEND;TZID=America/New_York:20250306T133000 DTSTAMP:20260503T074134 CREATED:20250131T142124Z LAST-MODIFIED:20250221T195549Z UID:13711-1741262400-1741267800@bionj.org SUMMARY:The New Trump Administration: Employment Law Update of What You Need to Know Now! DESCRIPTION:The New Trump Administration: Employment Law Update of What You Need to Know Now!\n\n\n\nThursday\, March 6\, 2025 | 12:00 p.m.-1:00 p.m. | Webinar\n\n\n\n\nRegister Today for FREE!\n\n\n\n\n\n\n\n\nMuch has happened in just the first few weeks of the Trump Administration. Many of the new directives directly impact the workforce and employee lifecycle. BioNJ is offering a FREE webinar to help our HR community understand the employment law aspects of these new developments. Join Lynne Anderson and her colleagues at Faegre Drinker for a discussion of how President Trump’s New Executive Orders impact HR.   \n\n\n\nTopics will include: \n\n\n\n\nThe immediate impact on DEI\, the OFCCP\, the EEOC\, AI and other workforce implications\n\n\n\nHow the recent changes to immigration policies impact the workplace.  \n\n\n\nWhat to expect regarding independent contractor classifications\, non-competes and what is happening with the NLRB\n\n\n\nHow New Jersey and other State laws need to be considered in tandem with the new Trump Executive Orders and policy developments \n\n\n\n\n*BioNJ has a new Membership Database. When registering\, you will need to start by clicking “Create Account”. If you have an account\, you’ll be prompted to reset your password. If not\, you’ll need to create a new account. Call 609-890-3185 should you need assistance. Thank you. \n\n\n\nSpeakers: \n\n\n\n\nLynne Anne AndersonPartnerFaegre Drinker  \n\n\n\nMs. Anderson is an experienced trial lawyer and strategic counselor with a long history of working with life sciences clients on all aspects of the employment relationship. She leads the firm’s Pay Equity Team and co-leads its Affirmative Action Task Force. Ms. Anderson has received multiple recognitions including by Chambers USA as a “Leading Lawyer for Business”.  She Co-Chairs BioNJ’s HR and Inspiring Women of STEM Committees; is a member of Faegre Drinker’s Health & Life Sciences Industry Team and Co-Chaired the firm’s ERG\, Women Forward\, from 2011 to 2023. \n\n\n\n\n\n\n\n\n\nBeth CarlsonPartnerFaegre Drinker  \n\n\n\nMs. Carlson is an experienced business immigration lawyer with over 25 years of experience moving corporate talent across borders and counseling U.S. and international companies on complex immigration issues across all industries\, including life sciences. She manages all types of U.S. employment-based immigration matters and leads the firm’s immigration team. Ms. Carlson also advises clients on changes to government policy\, including continued heightened scrutiny from USCIS\, the Department of Labor and other government agencies. \n\n\n\n\n\n\n\n\n\nBrian HayesAssociateFaegre Drinker  \n\n\n\nMr. Hayes counsels clients on a variety of employment-related issues\, including discrimination\, harassment\, retaliation\, wage and hour claims\, employee mobility and trade secrets\, breach of contract and defamation. He has deep experience advising clients on severance and release agreements\, restrictive covenants and trade secrets\, worker classification\, creating employee handbooks and policies\, reductions in force\, leaves of absence\, wage and hour compliance and other employment law developments. \n\n\n\n\nDon’t miss this important discussion. We hope to see you on March 6\, for this FREE educational webinar! Click here to register. URL:https://bionj.org/event/the-new-trump-administration-employment-law-update-of-what-you-need-to-know-now/ LOCATION:New Jersey CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2025/01/BioNJ-Logo_CMYK_2017.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250206T164500 DTEND;TZID=America/New_York:20250206T213000 DTSTAMP:20260503T074134 CREATED:20241204T142406Z LAST-MODIFIED:20250224T132049Z UID:13135-1738860300-1738877400@bionj.org SUMMARY:2025 BioNJ Annual Dinner Meeting & Innovation Celebration DESCRIPTION:Thursday\, February 6\, 2025 | 4:45 p.m.-9:30 p.m. | Hilton East Brunswick\n\n\n\n\nBecome a Sponsor\n\n\n\nPhoto Gallery\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAward Presentation byDr. Sol J. BarerFormer ChairCelgene Corp.ChairTeva Pharmaceutical \n\n\n\n\n\n\n\n\n\nDr. Sol J. Barer HonoreeJayne GershkowitzChief Patient AdvocateAmicus Therapeutics \n\n\n\n\n\n\n\n\n\nJohn CrowleyPresident & CEOBiotechnology Innovation Organization \n\n\n\n\n\n\n\n\n\nHusseini Manji\, M.D.Professor\, Oxford University; Co-Chair\, UK Gov’t Mental Health Mission & Former Global Head\, NeuroscienceJohnson & Johnson \n\n\n\n\n\nASCII\n\n\n\nGrace ElineBrain Cancer Survivor& Founder\, With Grace \n\n\n\n\n\n\n\n\n\nRegister today and join us for BioNJ’s 32nd Annual Dinner Meeting and Innovation Celebration\, taking place Thursday\, February 6\, 2025\, at the Hilton East Brunswick\, where we’ll celebrate the extraordinary innovation happening in the Garden State.   \n\n\n\nAs always\, many surprises are in store for an evening of inspiration and camaraderie. Kicking off the start of the New Year\, BioNJ’s Annual Dinner Meeting & Innovation Celebration features:  \n\n\n\n\nNetworking with biopharmaceutical professionals\, government officials\, academic leaders and professional service providers\n\n\n\nThe presentation of the Dr. Sol J. Barer Award for Vision\, Innovation and Leadershipby Dr. Barer himself to Chief Patient Advocate for Amicus Therapeutics Jayne Gershkowitz\n\n\n\nThe acclaimed Innovator Awards honoring 18 New Jersey companies that received a novel FDA drug approval in 2024\n\n\n\nThe presentation of the Heart of BioNJ Awards to Grace Eline\, Brain Cancer Survivor and Founder of With Grace\, and Dr. Husseini Manji\, Professor at Oxford Univ.\, Co-Chair of the UK Gov’t Mental Health Mission and Formal Neuroscience Global Head at Johnson & Johnson\n\n\n\nKeynote with President and CEO of the Biotechnology Innovation Organization John Crowley\n\n\n\nA Cocktail Hour\, Dinner Program and Dessert Reception\n\n\n\n\nDon’t miss this memorable evening celebrating New Jersey’s life sciences ecosystem and the Patients who inspire us. Registration for BioNJ Members is $540 and $625 for Future Members. Reserve a table for your Team today. Visit www.BioNJ.org for more information. \n\n\n\n*BioNJ has a new Membership Database. When registering\, you will need to start by clicking “Create Account”. If you have an account\, you’ll be prompted to reset your password. If not\, you’ll need to create a new account. Call 609-890-3185 should you need assistance. Thank you. \n\n\n\n\n\n\n\n\n\n\nContact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship Opportunities\, reserve a table and to place your organization in the spotlight.  URL:https://bionj.org/event/2025-bionj-annual-dinner-meeting-innovation-celebration/ LOCATION:Hilton East Brunswick\, 3 Tower Center Blvd\, East Brunswick\, NJ\, 08816\, United States CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/12/Annual-Dinner-Meeting-2025-Stacked.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250123T120000 DTEND;TZID=America/New_York:20250123T131500 DTSTAMP:20260503T074134 CREATED:20241211T224147Z LAST-MODIFIED:20250320T105240Z UID:13160-1737633600-1737638100@bionj.org SUMMARY:Securing the Future: Cyber Insurance\, Data Privacy & FDA Perspectives for 2025 DESCRIPTION:Securing the Future: Cyber Insurance\, Data Privacy & FDA Perspectives for 2025\n\n\n\nThursday\, January 23\, 2025 | 12:00 p.m.-1:15 p.m.\n\n\n\n\nRegister for FREE\n\n\n\n\nKick off 2025 with a comprehensive exploration of how cybersecurity risks are shaping the life sciences industry. As companies continue to innovate and bring groundbreaking therapies and products to market\, staying ahead of rapidly evolving cybersecurity regulations and threats is more important than ever. \n\n\n\nJoin BioNJ’s IT/Cybersecurity Awareness Committee on January 23 for an engaging virtual discussion\, “Securing the Future: Cyber Insurance\, Data Privacy & FDA Perspectives for 2025.” \n\n\n\nOur panel of experts will share valuable insights on these timely and critical topics: \n\n\n\n\nFDA & Cybersecurity: Focus\, expectations and enforcement plansgement\, Finance and Procurement and Research & Development (R&D) Facilities Management\n\n\n\n2024 Year-In-Review: Key trends in cybersecurity risks\n\n\n\n2025’s New Law: Preparing for the New Jersey Data Privacy Act\n\n\n\n\nHear From These Thought Leaders: \n\n\n\n\n\n\n\n\n\nScott Christie\, J.D.PartnerMcCarter & English \n\n\n\n\n\n\n\n\n\nKatherine ClarkVice PresidentCyber Client AdvisorMarsh \n\n\n\n\n\n\n\n\n\nShane MoylanVice PresidentCyber InsuranceMarsh  \n\n\n\n\n\n\n\n\n\nModerator Larry SamilowCo-Founder\, Managing DirectorVerve Group Consulting \n https://fullertonradiology.org \n\n\n\n\n\nDon’t miss this opportunity to gain practical knowledge and ask your pressing questions. Register today! URL:https://bionj.org/event/securing-the-future-cyber-insurance-data-privacy-fda-perspectives-for-2025/ LOCATION:New Jersey ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/12/IT-Cyber-2.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241210T000000 DTEND;TZID=America/New_York:20241210T235959 DTSTAMP:20260503T074134 CREATED:20240917T193337Z LAST-MODIFIED:20250320T105512Z UID:12670-1733788800-1733875199@bionj.org SUMMARY:BioNJ Gives Back: A Volunteer Opportunity to Help Patients DESCRIPTION:Tuesday\, December 10\, 2024 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAn Exclusive BioNJ Member Event \n\n\n\nDuring this year’s BioNJ Annual Dinner Meeting and Innovation Celebration\, Will Lewis\, the Chair and CEO of Insmed\, former BioNJ Chair and recipient of the 2024 Dr. Sol J. Barer Award\, delivered a heartfelt call to action. He urged our Members to consider actively engaging in community volunteering. \n\n\n\nIn response\, on December 10\, BioNJ will unite our Members for a collective giving initiative\, “BioNJ Gives Back.” During this volunteer program\, industry colleagues will have the opportunity to build a BioBear\, design a Superhero cape and write a heartfelt card for pediatric Patients throughout the State. \n\n\n\nBioNJ Member company representatives are invited to join us at either of our two volunteer locations to take part in this meaningful program. Member companies can send up to five participants at no charge*. Each participant will have the opportunity to build a BioBear\, design a Superhero cape and write a card which will be presented to a pediatric charity at the conclusion. \n\n\n\nTwo Locations/Times to Choose from on December 10: \n\n\n\n\n\n9:00 a.m.-11:00 a.m.Location: Insmed700 US 206Bridgewater Township\, NJ 08807  \n\n\n\n\nRegister for Insmed\n\n\n\n\n \n\n\n\n\n\n2:00 p.m.-4:00 p.m.Location: Genmab\, 777 Scudders Mill RoadPlainsboro\, NJ 08536 \n\n\n\n\nRegister for Genmab\n\n\n\n\n \n\n\n\n\n\nWe hope you will join us! Thank you for your consideration.If you’re having trouble registering\, please contact Randi Bromberg at RBromberg@bionj.org. \n\n\n\n*Registration is on a first-come\, first-served basis. Each location is limited to 150 volunteers. \n\n\n\n\n\n\n\nSuperhero Sponsor $10\,000 \n\n\n\n\n15 tickets (Each ticket is for one person to build a BioBear\, design a Superhero cape and write a card.)\n\n\n\nCompany logo on all promotions and the BioNJ website\n\n\n\nLogo on BioBear birth certificates\n\n\n\nPhoto opportunity with Patient organization leader as we present BioBears at the conclusion of the program at both sites\n\n\n\nAll participants will be invited to participate in a group photo\n\n\n\nExposure to media and legislators invited to the event (attendance not guaranteed)\n\n\n\n\nBioBear Sponsor $5\,000 \n\n\n\n\n10 tickets (Each ticket is for one person to build a BioBear\, design a Superhero cape and write a card.)\n\n\n\nCompany logo on all promotions and the BioNJ website\n\n\n\nLogo on BioBear birth certificates\n\n\n\nAll participants will be invited to participate in a group photo\n\n\n\nExposure to media and legislators invited to the event (attendance not guaranteed)\n\n\n\n\n\n\nHost Sponsors \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSuperhero Sponsor \n\n\n\n\n\nBioBear Sponsor \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nContact Randi Bromberg at RBromberg@BioNJ.org for more information or to become a sponsor! \n https://apothekebergheim.de URL:https://bionj.org/event/bionj-gives-back-a-volunteer-opportunity-to-help-patients/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/09/BioNJ-Gives-Back-2-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241206T083000 DTEND;TZID=America/New_York:20241206T143000 DTSTAMP:20260503T074134 CREATED:20240719T143909Z LAST-MODIFIED:20241024T122137Z UID:12386-1733473800-1733495400@bionj.org SUMMARY:2024 BioNJ Inspiring Women in STEM Conference DESCRIPTION:Friday\, December 6\, 2024 | 8:30 a.m.-2:30 p.m.Sanofi U.S.\, 55 Corporate Drive\, Bridgewater\, NJ 08807 \n\n\n\n\nRegister Today!\n\n\n\nBecome a Sponsor\n\n\n\n\nJoin us for BioNJ’s Tenth Annual Inspiring Women in STEM Conference on Friday\, December 6\, 2024. A thoughtfully curated agenda will allow participants to consider the most cutting-edge questions and essential and relevant topics of the day including Women’s Health Disparities\, AI-enabled Women’s Health\, and Powerful and Empowering Leadership\, wrapping up with a C-Suite leadership panel that is sure to inspire. Audience participation exercises and quality networking will make this a meaningful experience leaving attendees with actionable insights designed to inform\, involve and inspire. And this event promises to equip participants with the tools and ideas they need to impact their organizations. \n\n\n\n \n \n \n \n \n \n\n TimeCheck Out the Agenda\n\n\n\n \n 8:30 a.m. – 9:00 a.m.\nRegistration & Networking Breakfast \n \n \n 9:00 a.m. – 9:15 a.m.\nWelcome & Opening Remarks \n\nDebbie Hart\, President & CEO\, BioNJ\nRaquel Mura\, Head\, Global R&D Operations North America\, Sanofi\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n Time BE INFORMED: EDUCATIONAL TOPICS\n\n\n\n \n 9:15 a.m.– 10:15 a.m.\nPanel: Addressing Women’s Health Disparities and AdvocacyThis session will explore women's health disparities and advocacy efforts\, offering an historical perspective to contextualize current challenges and advancements. Experts will discuss recent developments\, upcoming trends and key areas for intervention\, while collaborating on actionable steps to empower advocacy and drive meaningful change in women's health.Panelists: \n\nRachel Braun Scherl\, Managing Partner & Co-Founder\, SPARK Solutions for Growth\nElizabeth Garner\, M.D.\, Former Chief Scientific Officer\, Ferring Pharmaceuticals US\, Immediate Past President\, American Medical Women's Association\nDenise Rodgers\, M.D.\, Vice Chancellor\, Interprofessional Programs\, Rutgers University\n\nModerated by: Jen Radin\, US Healthcare Advisory Sector Leader & Founding Partner\, Deloitte Health Equity Institute\, Deloitte \n \n 10:15 a.m.– 11:00 a.m.\nPanel: AI & Advancing Women’s HealthOur experts will delve into how AI technologies are revolutionizing diagnostics\, treatment options and personalized care for women worldwide. From predictive analytics to precision medicine\, discover how AI is reshaping healthcare delivery\, improving outcomes and promoting equity in women’s health initiatives.Panelists: \n\nNidhal Bouaynaya\, Ph.D.\, Associate Dean\, Henry M. Rowan College of Engineering\, and Professor of Electrical and Computer Engineering\, Rowan University\nBrianna Brennan\, Chief Innovation Officer\, Ontrak Health\nKirthika Parmeswaran\, Chief Executive Officer\, Vital Start Health\n\nModerated by:  Maureen Cruz\, Ph.D\, MPH.\, Director\, Science\, Regulation & Policy\, Faegre Drinker Biddle & Reath LLP \n \n \n 11:00 a.m. – 11:15 a.m.\nNetworking Break & Exhibitor Showcase \n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n Time BE INVOLVED: INTERACTIVE TOPICS TO PROMOTE ACTIONABLE TAKEAWAYS/STEPS FOR ALL\n\n\n\n \n 11:15 a.m. – 11:45 a.m.\nLeading From Where You Are: Women’s Power Advocacy & InfluenceKeynote by: Alison Fragale\, Ph.D.\, Speaker\, Professor & Compulsive OrganizerHow can women confidently advocate for their careers and ideas? Dr. Fragale will answer with six key strategies that anyone\, regardless of title\, can use to speak up and influence effectively without being seen as "aggressive" or "self-promoting." She'll discuss the importance of setting long-term goals\, excelling in performance\, becoming an "other promoter\," while developing your own narrative cultivating status and power and strategically saying yes or no. \n \n \n 11:45 a.m. – 12:00 p.m.\nIntroduce Workshop / Table Discussion Topics \n \n \n 12:00 p.m. – 1:00 p.m.\nLunch & Table Discussions/Workshop & Exhibitor Showcase \n \n \n 1:00 p.m. – 1:30 p.m.\nDebrief on Table Discussions/Workshop \n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeBE INSPIRED: INSIGHTS TO INSPIRE \n\n\n\n \n 1:30 p.m. – 2:30p.m.\nPanel: Women C-Suite Executive PanelJoin us for an inspiring panel where leaders will share their personal journeys and insights on navigating the C-Suite. You'll gain valuable perspectives on leadership\, innovation and overcoming challenges in both corporate and entrepreneurial settings. Whether you're aiming to advance your career\, reach the C-Suite or become an entrepreneur\, this session offers invaluable lessons and inspiration from accomplished women shaping today’s business world.Panelists: \n\nJennifer D'Angelo\, Chief Operating Officer & Executive Vice President\, Healthcare\, New Jersey Innovation Institute\nSandy Milligan\, M.D.\, J.D.\, President\, Research & Development\, Laboratory Operations\, IT & HR\, Aspira Women's Health \nEileen Morrissey\, Founder & CEO\, MedifVU\nKatie Sugarman\, M.D.\, Senior Vice President & Head\, Clinical Strategy\, Genmab\n\nModerated by: Cecilia Fong\, Director\, Business Insights & Analytics\, Genmab \n \n \n 2:30 p.m.\nClosing Remarks \n \n \n \n \n \n \n\n\n\n\n\nThank You to Our Sponsors\n\n\n\n\n\n\nRegister today and plan to join us at the Inspiring Women in STEM Conference on December 6\, 2024. Please share with colleagues and clients who can benefit from this informative program. Registration for BioNJ Members is $330 and $430 for Future Members. Bring your entire Team! \n\n\n\nClick here or contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities. Call (609) 890-3185 with any questions. URL:https://bionj.org/event/2024-bionj-inspiring-women-in-stem-conference/ LOCATION:Stevens Institute of Technology\, 1 Castle Point Terrace\, Hoboken\, New Jersey\, 07030\, United States CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/07/IWSTEM-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241121T120000 DTEND;TZID=America/New_York:20241121T131500 DTSTAMP:20260503T074134 CREATED:20241023T114719Z LAST-MODIFIED:20241104T185543Z UID:12952-1732190400-1732194900@bionj.org SUMMARY:BioNJ Finance Webinar DESCRIPTION:Post-Election Insights: Navigating Economic\, Tax & Policy Changes in Life Sciences\n\n\n\nThursday\, November 21\, 2024 | 12:00 p.m.-1:15 p.m.\n\n\n\n\nRegister for FREE\n\n\n\n\nJoin us for an engaging post-election webinar where industry experts will offer valuable insights into navigating the evolving landscape of economic\, tax and policy changes impacting the life sciences sector. This informative session promises to provide you with the strategies and knowledge needed to stay ahead in these rapidly changing times. \n\n\n\nTopics include: \n\n\n\n\nPost Election Discussion and the Impact on the Economy and the Industry\n\n\n\nMacro Environment & Trends\n\n\n\nTax & Policy Update\n\n\n\n\nDon’t miss this opportunity to stay ahead in today’s dynamic environment. \n\n\n\nOur Experts Include: \n\n\n\n\n\n\n\n\n\nTaylor HittleSenior ManagerWashington CouncilEY \n\n\n\n\n\n\n\n\n\nFred GordonSenior DirectorWashington NationalRSM \n\n\n\n\n\n\n\n\n\nMichael StrazzellaCo-ChairGovernment RelationsBuchanan Ingersoll& Rooney \n\n\n\n\n\n\n\n\n\nModerator:Sanjeev NarulaCFOIntra-Cellular Therapies \n\n\n\n\n\nWhether you’re involved in M&A\, technology\, finance or in the broader economic landscape\, this webinar offers valuable insights tailored to pique your interests and expertise. Click here to register at no cost. \n\n\n\nWho should attend this webinar: \n\n\n\nThis webinar is ideal for financial professionals\, investors\, business leaders\, policymakers and anyone interested in understanding the current state and future trends of the capital markets and the economy. \n\n\n\nThank You to Our Sponsors URL:https://bionj.org/event/bionj-finance-webinar/ LOCATION:New Jersey ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/09/BioNJ-Logo_CMYK_2017.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241118T090000 DTEND;TZID=America/New_York:20241118T163000 DTSTAMP:20260503T074134 CREATED:20240318T181310Z LAST-MODIFIED:20241118T133412Z UID:11218-1731920400-1731947400@bionj.org SUMMARY:2024 BioNJ AI & Digital Health Day DESCRIPTION:Register Today\n\n\n\nBecome a Sponsor\n\n\n\n\nNovember 18\, 2024 | 9:00 A.M. – 4:30 P.M.Stevens Institute of Technology\, 1 Castle Point Terrace\, Hoboken\, NJ\n\n\n\nThe event today is at the Tech Flex space in University Center Complex (UCC). You should have received an email from BioNJ which includes more details about the location and links to a campus map. The building is about halfway between the Howe Center and Babbio Center. Please plan to arrive early. Hoboken is congested in the morning\, and it can take time to get to campus. We look forward to seeing you there! \n\n\n\nJoin BioNJ\, in partnership with Morgan Stanley and DLA Piper and hosted by Stevens Institute of Technology\, on November 18 for our 2nd Annual AI & Digital Health Day.  \n\n\n\nFeaturing an exhilarating full-day program\, we’ll: \n\n\n\n\nExplore the latest trends in AI and digital health and how they are already impacting the life sciences industry\n\n\n\nDive into the challenges faced by entrepreneurs as they develop cutting-edge solutions to enhance Patient outcomes \n\n\n\nHear rapid-fire lightning pitches from entrepreneurial companies revolutionizing healthcare through AI-driven innovations (Interested in pitching? Click here to learn more and apply!)\n\n\n\n\nPlus\, entrepreneurs will have the opportunity to meet one-on-one to get advice from experts from financial\, legal\, investor and healthcare provider organizations at our Industry Help Desks.  \n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nCampus Maphttps://assets.ctfassets.net/mviowpldu823/1RHE112FrlUHseuZoPDsRM/a6feb431cdb732d2a565191de33dd298/Stevens-Campus-map-2024-web.pdf \n\n\n\nDriving Directionshttps://www.stevens.edu/driving-directions-to-stevens \n\n\n\nVisit Websitehttps://www.stevens.edu/admission-aid/visit-stevens \n\n\n\nParking Resources \n\n\n\n*We recommend taking public transportation if you are able and leaving time to find parking* \n\n\n\nOff-Campus ParkingThere may be parking spaces available on nearby city streets\, but visitors should abide by the parking signs posted by the City of Hoboken. Parking in “Resident Only” spaces or on the side of a street scheduled for cleaning will result in a vehicle being ticketed\, booted\, or towed. \n\n\n\nHoboken Municipal Garages \n\n\n\n\nGarage D at 215 Hudson St.\n\n\n\nGarage D Parking | Find Parking | ParkMobile – this is the closest municipal parking lot to the University Center Complex at the Stevens Institute. Parking reservations can be made via this link.\n\n\n\nGarage G at 315 Hudson St.\n\n\n\n\nHoboken Private Garages \n\n\n\n\nRiver Street Garage at 333 River St.\n\n\n\nMaxwell Place Garage at 1025 Maxwell Ln.\n\n\n\nIndependence Garage at 2 12th St.\n\n\n\nLittle Man Parking Garage at 225 River St.\n\n\n\n\nThe following apps might be helpful in reserving spots in these private garages:Search | Propark MobilitySpotHeroParkChirp \n\n\n\nRegister today and join an audience of entrepreneurs and industry professionals that support the life sciences and digital health ecosystem for this timely and informative discussion. Registration is $100 for BioNJ Members and $150 for Future Members. Contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities. \n\n\n\nThank You to Our Sponsors URL:https://bionj.org/event/2024-bionj-ai-digital-health-day/ LOCATION:Stevens Institute of Technology\, 1 Castle Point Terrace\, Hoboken\, New Jersey\, 07030\, United States CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/03/AI-Digital-Health-Color-With-Sponsors.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241114T083000 DTEND;TZID=America/New_York:20241114T150000 DTSTAMP:20260503T074134 CREATED:20240613T123711Z LAST-MODIFIED:20241113T124114Z UID:12128-1731573000-1731596400@bionj.org SUMMARY:2024 BioNJ Patient Advocacy Summit DESCRIPTION:The Power of the Patient’s Voice\n\n\n\nThursday\, November 14 • 2024\, 8:30 a.m.-3:00 p.m.\n\n\n\nBristol Myers Squibb • 556 Morris Ave\, Summit\, NJ 07901 \n\n\n\nAttendance is open and free to ALL Patient Advocacy Groups and R&D company Patient advocacy and government affairs professionals.  \n\n\n\n\nRegister Now\n\n\n\nBecome a Sponsor\n\n\n\n\n\n\n\n\nJoin us for this dynamic and educational discussion that will leave us all inspired and armed with new tools to make a difference on behalf of Patients!  \n\n\n\nBioNJ’s Patient Advocacy Summit will bring together Patients\, Patient Advocacy Groups\, Caregivers\, Clinicians and R&D Professionals for a day of Education\, Engagement and Empowerment. Attendees will gain valuable tools and insights\, share best practices and meet key stakeholders within the health care ecosystem.  \n\n\n\nAttendance is open and free to ALL Patient Advocacy Groups and R&D company Patient advocacy and government affairs professionals.  \n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nThank You to Our Sponsor URL:https://bionj.org/event/2024-bionj-patient-advocacy-summit/ LOCATION:Bristol Myers Squibb\, 3401 Princeton Pike\, Lawrence Township\, NJ\, 08648\, United States CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/BioNJ_PPA-Summit_Logo_copy-copy.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241112T080000 DTEND;TZID=America/New_York:20241112T150000 DTSTAMP:20260503T074134 CREATED:20241015T150320Z LAST-MODIFIED:20241015T150640Z UID:12871-1731398400-1731423600@bionj.org SUMMARY:7th Annual Symposium for Life Science Innovation and Development DESCRIPTION:***Not a BioNJ Hosted Event*** \n\n\n\nA Special Full-Day Conference for Life Science\, Design and Real Estate Professionals \n\n\n\nBringing the life sciences innovation community together \n\n\n\nLaunched in 2018\, NY Metro Builds Bio+ focuses on the growth and development of the life science cluster in the Greater New York Metro area (which includes New York City and the surrounding counties of New York\, Connecticut\, New Jersey and Pennsylvania). NY Metro Builds Bio+ hosts a series of events and educational initiatives and generates research and reports. \n\n\n\nA 501(c)(3) nonprofit membership-driven organization\, NY Metro Builds Bio+ is dedicated to bringing the life sciences innovation community together\, serving as the go-to place to find information about and assistance with growing\, building and locating life science companies in the New York Metropolitan area.Join us at the Seventh Annual Symposium for Life Science Innovation and Development to hear how private and public investments are driving exponential growth for the life science industry\, what new initiatives are furthering innovation in the space and what this means for the Greater NY Metropolitan Area.The symposium will also highlight a new London/UK life sciences chapter and we’ll present the research report from the London life sciences study tour which took place in April 2024. \n\n\n\nClick here for more information. URL:https://bionj.org/event/7th-annual-symposium-for-life-science-innovation-and-development/ LOCATION:New Jersey CATEGORIES:Industry Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241107T120000 DTEND;TZID=America/New_York:20241107T130000 DTSTAMP:20260503T074134 CREATED:20241022T124806Z LAST-MODIFIED:20250320T105945Z UID:12921-1730980800-1730984400@bionj.org SUMMARY:Health Equity in Clinical Trials New Jersey Participant Demographics DESCRIPTION:Webinar: Health Equity in Clinical TrialsNew Hersey Participant Demographics \n\n\n\nThursday\, November 7\, 2024 | 12:00 p.m.-1:00 p.m. \n\n\n\n\nRegister for FREE!\n\n\n\n\nBe among the first to hear the findings in BioNJ’s newly published whitepaper\, “Health Equity in Clinical Trials: New Jersey Participant Demographics\,” presented in partnership with Medidata\, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry. \n\n\n\nClinical trials represent a $15.2 billion industry in the U.S.\, with a continuing need for increased participation. \n\n\n\nTherefore\, this pioneering research tackles a critical goal: supporting the recruitment of underrepresented communities in clinical trials\, specifically in New Jersey\, while comparing New Jersey’s recruitment performance with similar states\, such as Connecticut\, Maryland\, Massachusetts and New York. \n\n\n\nJoin us on November 7 as our experts share key findings\, shed light on demographic recruitment variations across states and define crucial public policy opportunities to pursue more accurate demographic representation according to epidemiological data. \n\n\n\nBy attending\, you’ll gain insights to help ensure that clinical trials more accurately reflect and serve the diverse populations they aim to benefit. Click here to register for free. \n\n\n\nHear from: \n\n\n\n\n\n\n\n\n\nCaroline Der Nigoghossian\, PharmD\, MS\, BCCCPSenior Clinical Engagement Lead Medidata AI LabsMedidata Solutions \n\n\n\n\n\n\n\n\n\nIan McLaughlin\, Ph.D.Vice PresidentGovernment AffairsBioNJ \n\n\n\n\n\n\n\n\n\nEvon Okidi\, ScM\, MSSenior Data ScientistMedidata Solutions \n\n\n\n\n\nClick here to download a copy of “Health Equity in Clinical Trials: New Jersey Participant Demographics“. \n https://lancewallnau.com URL:https://bionj.org/event/health-equity-in-clinical-trials-new-jersey-participant-demographics/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/10/HECT-Outlines-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241024T170000 DTEND;TZID=America/New_York:20241024T190000 DTSTAMP:20260503T074134 CREATED:20241007T140338Z LAST-MODIFIED:20241023T114810Z UID:12860-1729789200-1729796400@bionj.org SUMMARY:Life Sciences Alternative Funding Panel DESCRIPTION:Join us at the New Jersey Bioscience Center for insights into alternative sources of funding to advance life sciences companies in New Jersey. \n\n\n\nThis panel discussion will focus on securing funding from non-traditional sources\, and will address the following questions: \n\n\n\n\nHow will the next generation of drugs\, diagnostics\, and devices be funded?\n\n\n\nWhat new models are there that might change the paradigm?\n\n\n\nIs there a better way to fund early and emerging commercial biomedical research?\n\n\n\n\nPanelists Include: \n\n\n\n\nJosh Barer\, Managing Director at Hibiscus BioVentures\n\n\n\nJudith Sheft\, Executive Director\, NJ CSIT\n\n\n\nJorge Ramirez\, Vice President\, M&A and Business Development\, Quest Diagnostics\n\n\n\n\nModerated by John Pennett\, Partner\, Life Sciences and Technology Group\, Eisner Advisory Group LLC URL:https://bionj.org/event/life-sciences-alternative-funding-panel/ LOCATION:New Jersey CATEGORIES:Industry Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241022T120000 DTEND;TZID=America/New_York:20241022T130000 DTSTAMP:20260503T074134 CREATED:20240926T131152Z LAST-MODIFIED:20240926T131327Z UID:12772-1729598400-1729602000@bionj.org SUMMARY:Positioning Early Cell Therapy for Clinical Success: Mitigating Risk & Ensuring GMP Readiness DESCRIPTION:Positioning Early Cell Therapy for Clinical Success: Mitigating Risk & Ensuring GMP Readiness\n\n\n\nTuesday\, October 22\, 2024 | 12:00 p.m.-1:00 p.m. | Virtual \n\n\n\n\nREGISTER TODAY FOR FREE!\n\n\n\n\nThe promise of cell therapies is often tempered by the many complexities of transitioning these innovations from R&D to the clinic. For early phase programs\, there are many aspects to consider\, from understanding evolving regulatory guidelines and reviewimg pathway options to addressing common manufacturing-related issues such as scalability\, high cost of goods\, and workforce retention. Additionally\, organizing and executing a successful cell therapy clinical trial can be challenged by a limited number of qualified clinical sites with experience in conducting advanced therapy studies\, access to desired Patient populations\, and managing the complex supply chain required to deliver therapies to Patients in a timely fashion. \n\n\n\nThrough a series of brief presentations on three key topic areas\, this webinar will help early phase cell therapy developers identify insights to mitigate risk and ensure clinical readiness to position their programs for success. \n\n\n\nSpecific topic areas of focus include: \n\n\n\n\nNavigating an evolving cell therapy regulatory landscape\n\n\n\nHow to assess GMP-readiness and prepare your cell therapy workflow for clinical and commercial manufacturing\n\n\n\nEnsuring patient-centricity in the complex cell therapy ecosystem and leveraging a unique\, comprehensive operating model for your product\n\n\n\n\nLearning objectives: \n\n\n\n\nStrategies to navigate regulatory hurdles and maximize impact of meetings with regulators\n\n\n\nBest practices to address common challenges in cell therapy process development and manufacturing\n\n\n\nOpportunities for a more streamlined\, Patient-centric approach to cell therapy clinical trials\n\n\n\nBenefits of working with an integrated CRO/CDMO partner to simplify the cell therapy value chain and improve Patient-centricity\n\n\n\n\nPresenters: \n\n\n\n\nMichele DugganSr. Manager\, Regulatory AffairsThermo Fisher Scientific  \n\n\n\nMs. Duggan joined Thermo Fisher Scientific in 2021 as Sr. Manager Regulatory Affairs supporting the development and delivery of regulatory solutions for customers within the biologics and advanced therapies pharma services manufacturing network. Prior to joining Thermo Fisher Scientific\, she spent over 17 years in CMC regulatory consulting\, providing regulatory strategy\, dossier authoring and review expertise for biologics and cell therapy products across all stages of the product life cycle. \n\n\n\n\n\n\n\n\n\nMindy Sadik\, Ph.D.Director\, Cell Therapy SciencesThermo Fisher Scientific  \n\n\n\nDr. Sadik oversees the Process Development and Analytical Development teams for the Cell Therapy Business unit for Advanced Therapies. Dr. Sadik’s teams work closely with partners to provide development and clinical scale services\, which include gene and non-gene modified cell processing for autologous and allogeneic cell therapies. This work includes technology transfer from the client to Thermo Fisher’s site\, process optimization and workflow readiness for transition into GMP manufacturing.  \n\n\n\n\n\n\n\n\n\nKim Watanabe\, Ph.D.Executive Director\, Cell and Gene Therapy Pillar HeadThermo Fisher Scientific  \n\n\n\nDr. Watanabe recently joined PPD\, part of Thermo Fisher Scientific\, where she leads business and operational strategy development and deployment in hematology and oncology clinical development services. She has 20 years of experience in R&D\, business and operations\, of which the last 14 years have been focused on cell and gene therapies. Prior to her current role\, Dr. Watanabe served as General Manager and Site Head for the Patheon Translational Services. Prior to her current role\, she served as GM/ Site Head for the Patheon Translational Services\, part of the contract development and manufacturing organization of Thermo Fisher Scientific. \n\n\n\n\n\n\n\n\nRegister today and join us on October 22 for this FREE educational webinar. Come ready to learn and ask questions! URL:https://bionj.org/event/positioning-early-cell-therapy-for-clinical-success-mitigating-risk-ensuring-gmp-readiness/ LOCATION:New Jersey END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241010T073000 DTEND;TZID=America/New_York:20241010T163000 DTSTAMP:20260503T074134 CREATED:20240318T181526Z LAST-MODIFIED:20241002T120610Z UID:11216-1728545400-1728577800@bionj.org SUMMARY:2024 BioNJ C-Suite Summit DESCRIPTION:THIS EVENT IS CLOSED TO THE MEDIA \n\n\n\nAn Inflection Point for Innovation in Life Sciences\n\n\n\nThursday\, October 10\, 2024 | 7:30 a.m.-4:30 p.m. Bridgewater Marriott\, 700 Commons Way\, Bridgewater\, NJ \n\n\n\n\nRegister Today\n\n\n\nBecome a Sponsor\n\n\n\n\nAgainst a backdrop of change\, the biopharmaceutical industry – and the next wave of innovation – are at an inflection point. Join us to reflect on the state of innovation in life sciences and how companies can best navigate through this period of continued change. \n\n\n\n \n \n \n \n \n \n\n TimeAGENDA\n\n\n\n \n 7:30 a.m. – 8:15 a.m.Registration & Networking Breakfast \n \n \n8:15 a.m. – 8:20 a.m.\n\n Welcome & Opening Remarks \n\nDebbie Hart\, President & CEO\, BioNJ\nEmer Leahy\, MBA\, Ph.D.\, President & CEO\, PsychoGenics & Chair\, BioNJ\n\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeINNOVATION\n\n\n\n \n \n8:20 a.m. – 8:50 a.m.\n\nKeynote: The Next Wave of Innovation in Life Sciences \nLife sciences leaders are navigating a period of exciting innovation. Novel modalities and mechanisms of action have helped the industry address previously stubborn unmet needs. Over the past 10 years\, R&D spend has increased\, the pipeline has become more diverse and new asset approvals have accelerated. Looking ahead\, policy reforms (e.g.\, IRA)\, a rapid proliferation in technological resources (e.g.\, AI\, mRNA platforms) and a rise in cross-company collaborations suggest further change and opportunity. Join us in reflecting on what the future of life sciences innovation holds\, and implications for large cap pharma companies\, biotechs and life sciences investors.  \n\nBrandon Parry\, MBA\, Sr. Partner\, McKinsey & Company\n\n \n \n \n8:50 a.m. – 9:45 a.m.\n\nPanel: Harnessing Change to Deliver Impactful Innovation \nIndustry leaders will reflect on the state of innovation\, expected industry shifts\, latest thinking on development paradigms\, portfolio shifts\, the lasting implications of policy reforms\, the impact of technological evolutions\, talent priorities and more. \n\nGarrett Ingram\, President & CEO\, Cipla Therapeutics\nWill Lewis\, MBA\, J.D.\, Chair & CEO\, Insmed\nClive Meanwell\, M.D.\, Chair & Partner\, Population Health Partners\nTarek Rabah\, MBA\, President & CEO\, Otsuka Pharmaceuticals\nScott White\, MBA\, Chief Operations Officer\, NA Innovative Medicine\, Johnson & Johnson\nConversation Leader: Harriet Keane\, Ph.D.\, Partner\, McKinsey & Company\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimePOLICY\n\n\n\n \n \n9:45 a.m. – 10:15 a.m.\n\nFireside Chat: Policy Uncertainties in an Election Year \nThe past 18 months have borne witness to a rapidly evolving policy landscape (including but not limited to the IRA\, IP\, BIOSECURE) – with expected evolutions on the horizon compounded by a tumultuous election season. With the presidential election just a few weeks away\, this session will explore potential health policy changes and implications for industry leaders. \n\nHon. Jim Greenwood\, Former Congressman & Former President & CEO\, BIO \nHeather Meade\, Principal\, EY\nConversation Leader: Lisa LeCointe-Cephas\, J.D.\, Partner\, Compliance & Investigations & Global Chair\, Life Sciences Sector\, DLA Piper\n\n \n \n 10:15 a.m. – 10:30 a.m.\nNetworking Break \n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeMARKET ACCESS\n\n\n\n \n 10:30 a.m. – 11:15 a.m.\nPanel: Market Access & ReimbursementThe market access landscape is intricate and constantly evolving\, with payers persistently refining their business models and strategies. This panel will explore the essential groundwork for securing optimal reimbursement and payer coverage\, which are crucial for ensuring Patient access to treatments and\, ultimately\, improving Patient care. The panel will also address key issues manufacturers face including changing legislation\, consolidation\, M&A\, gross to net and commercial launch planning. \n\nPaul Hunter\, Vice President\, Market Access and Commercial Operations\, Halozyme\nChristopher Jackson\, J.D.\, Managing Member\, The Law Office of Christopher S. Jackson\nJake McDowell\, Vice President\, Head\, Market Access\, Pricing and Value\, Partner Therapeutics\nConversation Leader: Tom Evegan\, Principal\, Strategy & Management Consulting; National Consulting Leader Life Sciences\, RSM\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeTALENT\n\n\n\n \n 11:15 a.m. – 12:00 p.m.\nPanel: Topics in Talent: Attraction\, Retention & DiversityIn the life sciences sector\, talent development is crucial for fostering innovation and addressing complex challenges. Companies are focused on developing the next generation of talent by providing opportunities for education\, training and mentorship. Additionally\, there is a growing emphasis on upskilling and reskilling talent to leverage AI and other advanced technologies for greater efficiency and effectiveness. This discussion will explore key learnings from workplace evolutions and strategies companies can and must adopt such as equity. \n\nBritt Byers\, Executive Vice President\, Human Resources NA\, Kyowa Kirin\nVikki Conway\, Sr. Vice President & Head\, Human Resources\, U.S.\, Teva Pharmaceuticals\nKiran Dattani\, MPH\, MBA\, Customer Success\, Transformation\, Strategy & Architecture\, Google Cloud Healthcare & Life Sciences\, Google\nConversation Leader: Jan Campbell\, Managing Partner Pharmaceuticals & Biotechnology\, Korn Ferry\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeRESEARCH & DEVELOPMENT\n\n\n\n \n 12:00 p.m. – 12:30 p.m.\nFireside Chat: Research & Development in Mental HealthWith Global Mental Health Day as the backdrop\, this discussion features two pioneers in mental health research and development and will explore the challenges in developing therapeutics in the mental health space and how they can provide learnings in other areas. \n\nHusseini Manji\, M.D.\, F.R.C.P.C.\, Professor\, Oxford University; Co-Chair\, UK Govt MH Mission; Former Global Head\, Neuroscience\, Janssen/Johnson & Johnson\nConversation Leader: Emer Leahy\, MBA\, Ph.D.\, President & CEO\, PsychoGenics & Chair\, BioNJ\n\n \n \n 12:30 p.m. – 1:30 p.m.\nNetworking Lunch \n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeCOMMERCIALIZATION & PATIENT SERVICES\n\n\n\n \n 1:30 p.m. – 2:15 p.m.\nPanel: Continued Evolutions in Go-to-Market Models Including Patient ServicesThe continued evolution of the go-to-market (GTM) commercial model in life sciences has been characterized by a shift from push to pull strategies\, the development of novel roles that rethink traditional functional boundaries in a compliant manner\, and a simplification of the customer interface. This talk will explore how these approaches can enhance and improve Patient access to treatments given the complex journey that is the Patient experience. Getting it right can have a major impact on Patient outcomes\, as Patient experience in healthcare continues to lag. personalized journeys. \n\nJohn Harlow\, Chief Commercial Officer\, Melinta Therapeutics\nRohan Jain\, General Manager\, Commercial\, Nusano\nGina Murdoch\, MBA\, President & CEO\, Multiple Sclerosis Association of America\nConversation Leader: Haripriya Jain\, MS\, MBA\, Executive Director\, Global Value & Access Consulting\,  Evidera\, part of Thermo Fisher Scientific \n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeCAPITAL MARKETS\n\n\n\n \n 2:15 p.m. – 3:00 p.m.\nPanel: Evolving Capital Markets & Implications for InnovationThe life sciences industry market cap has more than tripled in a decade despite more recent challenges. This discussion will explore the latest funding environment (e.g.\, IPOs) and implications for industry. \n\nAamir Mecklai\, Managing Director\, Healthcare Investment Banking\, Bank of America\nChristopher Mortko\,MBA\, Ph.D.\, Vice President\, Business Development & Licensing\, Merck & Co.\nMonika Vnuk\, M.D.\, Sr. Vice President\, Global Partnering & Business Development\, Sanofi\nConversation Leader: Arda Ural\, MBA\, Ph.D.\, Americas Life Sciences Sector Leader\, EY\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeAI & TECHNOLOGY\n\n\n\n \n 3:00 p.m. – 3:45 p.m.\nPanel: The Digital & AI Era in the Biopharma Industry: How Can Companies Across Functions Transition from Hype Into Reality?In the current environment\, the biopharmaceutical industry is experiencing a transformative shift towards digitalization and AI adoption\, promising improved efficiency\, innovation and Patient outcomes. However\, for companies to transition successfully from the hype surrounding these technologies into tangible benefits\, they must integrate digital and AI solutions across functions\, prioritize data-driven decision-making and foster a culture of innovation and adaptability. \n\nSydney Klein\, Chief Information Security Officer & Head of IT Core Services\, Bristol Myers Squibb\nHisham Hamadeh\, Ph.D.\, Sr. Vice President & Global Head\, Data Science & AI\, Genmab\nKeith Koharski\, MBA\, Executive Director\, Global Development IT\, Regeneron\nDeiva Ramachandran\, Ph.D.\, Partner\, Generative AI-Automation Practice Leader\, Healthcare\, Life Sciences\, State & Local Government\, IBM\nConversation Leader: Donna Conroy\, Founder\, CEO\, SciMar ONE\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nJoin us on October 10 for this important conversation. Registration is $695 for BioNJ Members and $895 for Future Members. (BioNJ is pleased to have maintained our pricing unchanged for the past three years.) Click here to register. \n\n\n\nThank You to Our Sponsors URL:https://bionj.org/event/2024-bionj-c-suite-summit/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/03/CSuite-Summit-2024.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240926T120000 DTEND;TZID=America/New_York:20240926T133000 DTSTAMP:20260503T074134 CREATED:20240719T135506Z LAST-MODIFIED:20240829T163911Z UID:12354-1727352000-1727357400@bionj.org SUMMARY:AI & Digital Health Webinar DESCRIPTION:The Path to Real Impact of AI on Healthcare and Life Sciences\n\n\n\nThursday\, September 26\, 2024 | 12:00 p.m.-1:30 p.m. | Virtual \n\n\n\n\nREGISTER TODAY FOR FREE!\n\n\n\n\nJoin us on September 26 for a complimentary webinar\, where leading industry experts will share insights into how they are leveraging AI and cutting-edge technology to drive innovation\, expand access and enhance Patient outcomes. Don’t miss this opportunity to gain valuable knowledge from those at the forefront of transformative advancements. \n\n\n\nSpeakers Include: \n\n\n\n\nKiran DattaniCustomer SuccessTransformation\, Strategy & Architecture Google Cloud \n\n\n\nMr. Dattani is a seasoned AI Specialist & Technologist with over 20 years of experience in the life sciences and pharmaceutical industries. He has a proven track record of driving AI & digital transformation\, automation and data science initiatives for leading organizations like Pfizer and Google. Mr. Dattani’s expertise spans AI healthcare practice\, enterprise architecture\, cloud enablement\, AI and data solution delivery. He has a passion for leveraging technology to improve Patient outcomes. \n\n\n\n\n\n\n\n\n\nSeemi KazmiExecutive DirectorProduct Management\, Digital HealthBristol Myers Squibb \n\n\n\nMs. Kazmi is Executive Director and Digital Health TA Lead for Cardiovascular and Neuroscience. She is responsible for defining digital health strategy and implementing innovative solutions across the pharma value chain\, both in commercial and clinical development. Ms. Kazmi is responsible for the global roadmap of a portfolio of solutions that includes first-in-class AI-based algorithms for Patient identification and clinical decision support\, biometric sensors/wearables for remote Patient monitoring\, tools integrated into EMRs and novel digital biomarkers of disease. \n\n\n\n\n\n\n\n\n\nScott OgdenHead\, AI LabsGenmab \n\n\n\nMr. Ogden heads up the AI Innovation Lab at Genmab\, where he’s focused on bringing leading\, novel solutions to the forefront of biotech. With a background in computation\, Mr. Ogden has spent his working years building healthcare innovation teams across the different sectors\, including payors and providers. He’s currently juggling his role at Genmab with working on his EMBA at Wharton\, studying entrepreneurship. During the program\, he will share some down-to-earth insights on how Genmab is using AI to push the envelope on the end-to-end drug development lifecycle. \n\n\n\n\n\n\n\n\n\nTroy Sarich\, Ph.D.Chief Commercial Data Science OfficerJohnson & Johnson Innovative Medicine \n\n\n\nDr. Sarich leads teams that leverage the power of artificial intelligence and machine learning\, real-world evidence (RWE)\, digital health and precision medicine across J&J’s global regions and multiple therapeutic areas. During his nearly 20-year tenure at J&J\, Dr. Sarich has delivered business transformation and Patient impact across the Innovative Medicine sector’s R&D and Commercial teams\, including as Vice President\, RWE\, Global Head of R&D Strategy\, founding co-chair and member of the J&J AI Council and in pivotal roles in the clinical development of INVOKANA® and XARELTO®. \n\n\n\n\n\n\n\n\nBioNJ is building a Directory of AI Service Providers. If you are a BioNJ Member and fit into this category\, send your company information to RBromberg@BioNJ.org! URL:https://bionj.org/event/ai-digital-health-webinar/ LOCATION:New Jersey ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/07/Digital-Health-Webinar.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240913T083000 DTEND;TZID=America/New_York:20240913T154500 DTSTAMP:20260503T074134 CREATED:20240501T201159Z LAST-MODIFIED:20240912T152127Z UID:11637-1726216200-1726242300@bionj.org SUMMARY:2024 BioNJ Manufacturing Briefing DESCRIPTION:Building the Future: Advancing Capabilities\, Technology and Talent for the Next Era of Biomanufacturing\n\n\n\nFriday\, September 13\, 2024 | 8:30 a.m.-3:45 p.m. Sanofi\, 55 Corporate Dr\, Bridgewater\, NJ \n\n\n\nRegistration is now closed for this event. We look forward to seeing everyone tomorrow at the program. Please contact Maria Carapucci at MCarapucci@BioNJ.org with any questions. Thank you.  \n\n\n\nBiopharma manufacturing has been evolving rapidly. Join us on September 13 for BioNJ’s Manufacturing Briefing where you’ll hear from and engage with thought leaders on timely and important topics affecting the industry. URL:https://bionj.org/event/2024-bionj-manufacturing-briefing/ LOCATION:Sanofi\, 55 Corporate Dr\, Bridgewater\, New Jersey\, 08807\, United States CATEGORIES:BioNJ Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240627T120000 DTEND;TZID=America/New_York:20240627T131500 DTSTAMP:20260503T074134 CREATED:20240523T201528Z LAST-MODIFIED:20240711T141128Z UID:11913-1719489600-1719494100@bionj.org SUMMARY:2024 BioNJ IT/Cyber Briefing Webinar DESCRIPTION:FREE Webinar: De-Risking Cybersecurity forEmerging Life Sciences Companies \n\n\n\nThursday\, June 27\, 2024 | 12:00 p.m.-1:15 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin BioNJ’s IT/Cybersecurity Awareness Committee on June 27 for a virtual discussion on “De-risking Cybersecurity for Emerging Life Sciences Companies.” Few industries are as heavily targeted by cybercriminals as life sciences. It’s easy to see why…given the immense value of Patient data\, research\, market insights and product information. And emerging life sciences companies face even greater risks\, as they often have limited operational budgets for cybersecurity personnel and infrastructure. \n\n\n\nDuring this content-dense webinar\, we’ll hear from current life sciences CEOs\, CFOs and CIOs about the real-world cybersecurity challenges facing emerging companies. Additionally\, cybersecurity industry experts — including the FDA — will share some of the practical ways to address those challenges.  \n\n\n\nRegister today and come ready to ask our experts questions. \n\n\n\nHear from These Thought Leaders\n\n\n\n\n\n\n\n\n\nJim AmbrosiniChief InformationSecurity OfficerCompassMSP \n\n\n\n\n\n\n\n\n\nSusan BlumChief Financial OfficerMelinta Therapeutics \n\n\n\n\n\n\n\n\n\nDaniel BurkeDivision Chief\, Cyber OperationsOffice of Criminal InvestigationsU.S. Food and DrugAdministration \n\n\n\n\n\n\n\n\n\nPaul FangSr. Director\, InformationSecurity & ComplianceBeiGene \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRandy MilbyCEO & ChairTharimmune \n\n\n\n\n\n\n\n\n\nMark PelligrinoSr. Vice PresidentChief Information OfficerInsmed \n\n\n\n\n\n\n\n\n\nChris RiosSr. Vice PresidentMarsh \n\n\n\n\n\n\n\n\n\nModeratorLarry SamilowCo-Founder & Managing DirectorVerve Group Consulting \n\n\n\n\n\nThank You to Our Sponsors URL:https://bionj.org/event/bionj-it-cyber-briefing-webinar/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/05/IT-Cyber.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240618T083000 DTEND;TZID=America/New_York:20240618T153000 DTSTAMP:20260503T074134 CREATED:20240318T175837Z LAST-MODIFIED:20240613T163705Z UID:11210-1718699400-1718724600@bionj.org SUMMARY:2024 BioNJ HR Conference DESCRIPTION:Flourishing at Work: Tools\, Tips\, and Trends \n\n\n\nTuesday\, June 18\, 2024 | 8:30 a.m.-3:30 p.m. \n\n\n\nKean University\, 1000 Morris Ave.\, Union\, NJ \n\n\n\nThis program is approved for 5.5 HR Certification Institute® (HRCI®) credits. \n\n\n\nJoin us for BioNJ’s 11th Annual HR Conference\, taking place at Kean University on June 18. Come ready to connect with other life sciences HR professionals\, learn from industry experts on issues affecting your organization and leave with best practices that will enable you to position your company and your employees for success.  \n\n\n\nBe part of the conversation. Knowledge is power and collaboration is crucial in creating new opportunities and growing the ecosystem. \n\n\n\n\nRegister Today\n\n\n\nBecome a Sponsor\n\n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\nLynne Anderson\, J.D.PartnerFaegre Drinker \n\n\n\n\n\n\n\n\n\nBrenda BurnerDirector\, Global CompensationMerck & Co. \n\n\n\n\n\n\n\n\n\nChristopher CozicExecutive Vice President & Chief People OfficerGenmab \n\n\n\n\n\n\n\n\n\nAndrew DicksonPrincipalMercer \n\n\n\n\n\n\n\n\n\nD’Angelique DopsonDirector Total Rewards Human ResourcesShionogi \n\n\n\n\n\n\n\n\n\n\n\nDebbie HartPresident & CEOBioNJ \n\n\n\n\n\n\n\n\n\nDawn KesslerDirector\, Site HR Lead USGenmab \n\n\n\n\n\n\n\n\n\nStela LupushorChief-Reframer\, Reframe.Work Inc. & Co-Author of “Humans at Work and Humanizing Human Capital” \n\n\n\n\n\n\n\n\n\nEileen McNeelyPh.D.\, M.S.\, R.N.Executive Director SHINE\, Human Flourishing ProgramHarvard University \n\n\n\n\n\n\n\n\n\nSally PaullExecutive Vice President Chief Human Resource OfficerRegeneron \n\n\n\n\n\n\n\n\n\n\n\nBetty Rivera-ManningRewards Business Partner/ US P&O Policy Lead Novartis \n\n\n\n\n\n\n\n\n\nDerrick Swinton\, Ph.D. Associate Dean for Research\, Dorothy and George Hennings College of Mathematics\, Science and TechnologyKean University \n\n\n\n\n\n\n\n\n\nLisha YangSenior Director\, Head of Operations Data Science & AIGenmab \n\n\n\n\n\n \n\n\n\n\n\n \n\n\n\n\n\nCome ready to gather new and creative ideas\, strategies and tactics for how to navigate today’s HR challenges and opportunities in the life sciences sector.  \n\n\n\nClick here to register now. Registration is $195 for BioNJ Members and $295 for Future Members. To learn about Sponsorship opportunities\, contact Cheri Hennessy at CHennessy@BioNJ.org or 609-890-3185.  \n\n\n\n\n\n\n\n\n\n\nDownload Kean Campus Map URL:https://bionj.org/event/2024-bionj-hr-conference/ LOCATION:Kean University\, 1000 Morris Ave\, Union\, New Jersey\, 07083\, United States CATEGORIES:BioNJ Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240521T120000 DTEND;TZID=America/New_York:20240521T131500 DTSTAMP:20260503T074135 CREATED:20240419T194030Z LAST-MODIFIED:20240520T183739Z UID:11558-1716292800-1716297300@bionj.org SUMMARY:Capital Markets Update / State of the Economy DESCRIPTION:FREE Webinar: Capital Markets Update / State of the Economy \n\n\n\nTuesday\, May 21\, 2024 | 12:00 p.m.-1:15 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin us for this insightful webinar where we’ll dive into crucial topics shaping the financial landscape. Our experts will discuss M&A collaborations and deals\, emerging technologies garnering funding and the impacts of the IRA. Plus\, you’ll gain valuable insights into the upcoming 2024 election’s potential ramifications on the economy. Don’t miss this opportunity to stay ahead in today’s dynamic market environment. Topics include: \n\n\n\n\nM & A Collaborations & Deals\n\n\n\nTechnologies that are being funded and those that are not\n\n\n\nIRA and its Impacts \n\n\n\nUpcoming 2024 Election\n\n\n\n\nSpeakers: \n\n\n\n\nKeith Gaub \n\n\n\nVice President & Assistant TreasurerBristol Myers Squibb \n\n\n\nMr. Gaub oversees Capital Markets\, Financial Risk Management\, International Treasury & International Treasury Operations\, Cash Leadership and Benefit Investments.  Prior to joining BMS\, he worked at Zoetis for nine years\, most recently serving as Senior Director of Investor Relations\, where he managed relationships with sell-side analysts and large institutional investors\, in addition to supporting their CEO and CFO during earnings announcements. \n\n\n\n\n\n\n\n\n\nCourtney Rickert McCaffrey \n\n\n\nGlobal Insights LeaderEY Geostrategic Business Group \n\n\n\nMs. McCaffrey drives market-leading insight around geopolitics\, corporate performance and political risk management. She leads the analysis of the annual EY Geostrategic Outlook and advises clients on how geopolitical developments may impact their companies’ operations and strategies\, and how to manage political risks more proactively. She is also the co-author of a forthcoming book entitled Geostrategy by Design: How to Manage Geopolitical Risk in the New Era of Globalization. \n\n\n\n\n\n\n\n\n\nPatrick Morley \n\n\n\nSenior Managing Director Equity Capital MarketsLeerink Partners \n\n\n\nMr. Morley is a Senior Managing Director in Leerink Partners’ Equity Capital Markets group\, advising private and public healthcare companies on the optimal strategy and tactics to achieve their financing goals. He joined the Firm in 2011 as a member of the Healthcare Investment Banking group before transitioning to his current role.  \n\n\n\n\n\n\n\n\n\nPhilip Sclafani \n\n\n\nPartnerPWC \n\n\n\nMr. Sclafani has deep experience supporting branded\, biotech\, generics\, medical device and other healthcare companies. He leads high performing teams to address his clients most challenging issues across strategy\, operations\, digital & analytics\, compliance and technology in the Pharma commercial organization\, medical affairs\, M&A / business development and other key functions. \n\n\n\n\n\n\n\n\n\nRoel van den Akker \n\n\n\nPharmaceutical and Life Sciences Deals LeaderPWC \n\n\n\nMr. van den Akker is PwC’s Pharmaceutical and Life Sciences Deals Leader\, with vast experience in transactions\, deals\, M&A and divestitures. He leads a team focused on helping pharma\, life sciences and med tech companies win through deals and seamlessly capture value during acquisitions. \n\n\n\n\n\n\n\n\n\nMODERATOR: Scott Megaffin \n\n\n\nPresident & CEOAdiso Therapeutics \n\n\n\nLeveraging his extensive experience as a biopharma senior executive\, Mr. Megaffin has guided both public and private companies as CEO and Board Director. His deep knowledge spans a broad range of therapeutic areas\, including immunology\, inflammation\, oncology\, anti-infectives\, pain\, critical care and virology. He currently applies his expertise beyond Adiso by serving on the board of BioNJ and Adastra. \n\n\n\n\n\n\n\n\n\n\n\nWhether you’re involved in M&A\, technology\, finance or in the broader economic landscape\, this webinar offers valuable insights tailored to pique your interests and expertise. Click here to register at no cost. \n\n\n\nWho should attend this webinar: This webinar is ideal for financial professionals\, investors\, business leaders\, policymakers and anyone interested in understanding the current state and future trends of the capital markets and the economy. URL:https://bionj.org/event/capital-markets-update-state-of-the-economy/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240513T073000 DTEND;TZID=America/New_York:20240517T170000 DTSTAMP:20260503T074135 CREATED:20231218T161943Z LAST-MODIFIED:20231220T184516Z UID:9936-1715585400-1715965200@bionj.org SUMMARY:2024 BioPartnering Conference DESCRIPTION:IN-PERSON PARTNERING\, EDUCATION & NETWORKING: Tuesday\, May 14\, 2024 | 7:30 a.m.-5:45 p.m.The Palace at Somerset Park\, Somerset\, NJ 08873Virtual Partnering: Monday\, May 13 & Wednesday-Friday*\, May 15-17\, 2024Registration for BioNJ Members is $425 and $525 for Future Members. *Full Conference Registration Required. \n\n\n\n\n\n\nBecome a Sponsor\n\n\n\n\n\n\n\n\nSave the date and plan to join us on May 14\, 2024 for BioNJ’s 14th Annual BioPartnering Conference\, the premier partnering event for entrepreneurs looking to connect with investors and biopharmaceutical companies for funding and collaboration opportunities. \n\n\n\nOur new Conference location ― the Liberty Science Center ― offers a spacious\, state-of-the-art venue to accommodate the important and numerous elements of the Conference\, including: \n\n\n\n\n1-1 partnering\n\n\n\nCompany and start-up pitch presentations\n\n\n\nIndustry Connections (office hours with top biopharmaceutical companies)\n\n\n\nExhibits\n\n\n\nPlenary sessions\n\n\n\nAnd lots of networking\n\n\n\n\nBioNJ’s BioPartnering Conference attracts life sciences executives\, investors\, academic collaborators and business development professionals from around the globe ― with the goal of fostering productive partnerships and facilitating investment opportunities. \n\n\n\nApplications for Company Pitch Presentations for the 2024 BioNJ BioPartnering Conference will open January 16\, 2024. Be on the lookout for email notifications. URL:https://bionj.org/event/2024-biopartnering-conference/ LOCATION:Liberty Science Center\, 222 Jersey City Blvd\, New Jersey\, 07305\, United States CATEGORIES:BioNJ Event,Entrepreneurs-Exchange,Past Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/12/BioP-Color.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240327T120000 DTEND;TZID=America/New_York:20240327T130000 DTSTAMP:20260503T074135 CREATED:20240220T153351Z LAST-MODIFIED:20240315T150421Z UID:10856-1711540800-1711544400@bionj.org SUMMARY:Top Priorities for Life Sciences CFOs in 2024: A Life Sciences CFO Roundtable DESCRIPTION:FREE Webinar: Top Priorities for Life Sciences CFOs in 2024: A Life Sciences CFO Roundtable \n\n\n\nQualifies for 1.0 CPE Credit in Specialized Knowledge. \n\n\n\nWednesday\, March 27\, 2024 | 12:00 p.m.-1:00 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin BioNJ and BDO on Wednesday\, March 27 for a roundtable discussion with life sciences CFOs about opportunities and risks facing the industry in 2024. \n\n\n\nThe webinar will discuss BDO’s 2024 Life Sciences CFO Outlook Survey\, which polled life sciences CFOs on their expectations for 2024. Below are some of the key issues this webcast will address. \n\n\n\n\nReview how life sciences CFOs are adjusting their cash management and investing strategies in response to ongoing economic volatility.\n\n\n\nDiscuss what tax strategies life sciences CFOs are pursuing to improve their financial standing — and what opportunities they may be missing.\n\n\n\nDescribe the treatments and drug modalities that life sciences CFOs will be prioritizing in 2024.\n\n\n\nExplain how life sciences organizations are addressing generative AI risks and concerns\, especially those related to data privacy.\n\n\n\n\nWho should attend: Private and Public Company Controllers\, Vice Presidents of Finance\, CFOs\, R&D Company CEOs\, Finance Team Members and Legal Counsel and others who are interested in the life sciences ecosystem. \n\n\n\nPanelists: \n\n\n\n\n\n\n\n\nAmit BhallaExecutive Vice President & Chief Financial Officer\, Sampled \n\n\n\nMr. Bhalla has more than 25 years of Wall Street and healthcare industry experience. His background in finance\, strategy and business development includes experience in equity investing as well as sourcing\, negotiating and integrating transformational and tuck-in M&A. Most recently\, Mr. Bhalla served as Senior Healthcare Analyst at Lord\, Abbett & Co. with responsibility for investments across all healthcare verticals in seven Lord Abbett funds. \n\n\n\n\n\n\n\n\n\nMike MaddenChief Financial Officer\, Lumanity \n\n\n\nMr. Madden is responsible for the Lumanity’s financial operations and functions. This includes financial strategy\, financial performance management\, capital allocation\, financial services\, controllership\, tax\, treasury and corporate strategy. Mr. Madden joined Lumanity in 2023 as an experienced finance leader\, with over 20 years of global finance and transformation experience. He possesses a proven track record of success with Fortune 250 financial institutions\, large multinational\, public\, and private equity backed companies. \n\n\n\n\n\n\n\n\n\nHarry PalminExperienced CFO \n\n\n\nMr. Palmin has a successful track record of building\, financing and operating public/private life sciences companies for 25 years\, having taken 3 companies public. He served as CFO at Acer Therapeutics from 2016 until the sale to Zevra Therapeutics in November 2023. Mr. Palmin took Acer public in 2017 achieving a $330 million peak market capitalization and raised $172 million in pursuit of Acer’s drug development and commercial objectives culminating in OLPRUVA® approval in December 2022. \n\n\n\n\n\n\n\n\n\nSarah RomanoCPA\, Chief Financial Officer\, First Wave BioPharma \n\n\n\nBefore joining First Wave BioPharma in March 2022\, Ms. Romano held the position of Chief Financial Officer at Kiora Pharmaceuticals\, a clinical-stage specialty pharmaceutical company focused on ophthalmic disease treatments\, from February 2017 to February 2022. Earlier\, she served as Corporate Controller at Kiora Pharmaceuticals from August 2016 to January 2017. Prior to that\, Ms. Romano worked as an Assistant Controller at TechTarget and as Corporate Controller at Bowdoin Group\, a healthcare-oriented executive recruitment firm. \n\n\n\n\n\n\n\n\n\nModerator \n\n\n\nDouglas E. Gustin\, CPAAssurance Principal\, BDO \n\n\n\nMr. Gustin has over 20 years of combined experience in public and private accounting working primarily with middle-market companies in technology\, manufacturing and life sciences industries. His client service experience includes working on SEC engagements\, including accelerated and large accelerated issuers as well as private equity\, venture backed and family-owned businesses. Mr. Gustin has extensive experience working with other BDO International member firms. \n\n\n\n\n\n\n\n\nThe life sciences industry is changing. Learn what opportunities and risks could await life sciences companies in 2024 and how to plan ahead. \n\n\n\nWe hope to see you on March 27\, 2024 for this FREE educational webinar. URL:https://bionj.org/event/bdos-life-sciences-cfo-outlook-survey-live-sciences-resets-and-refocuses/ LOCATION:New Jersey CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240306T120000 DTEND;TZID=America/New_York:20240306T130000 DTSTAMP:20260503T074135 CREATED:20240130T152008Z LAST-MODIFIED:20240130T152134Z UID:10742-1709726400-1709730000@bionj.org SUMMARY:Integrating AI and Robotics to Discover New Drugs Faster DESCRIPTION:FREE Webinar: Integrating AI and Robotics to Discover New Drugs Faster \n\n\n\nWednesday\, March 6\, 2024 | 12:00 p.m.-1:00 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin us for this one-hour webinar where experts will use Iktos’ AI-driven platform to explore the synergy between artificial intelligence and robotics in the design and synthesis of novel molecules for drug discovery and optimization.  \n\n\n\nFrom handling diverse molecules\, reactions and exit vectors to optimizing reactants\, procedures and the number of steps\, this groundbreaking approach is poised to reshape the future of drug discovery.  \n\n\n\nBy streamlining research processes and addressing current weaknesses related to sub-optimal workflows and time-consuming manual tasks\, AI solutions have the potential to deliver a drug candidate within 24 months with just two chemists and one robot\, a significant reduction compared to the conventional requirement of 10 people and 30 months. \n\n\n\nInvite your entire Team to attend this FREE webinar\, including your scientists\, researchers\, R&D leads and business development professionals! \n\n\n\nSpeakers: \n\n\n\n\n\n\n\n\nQuentin Perron\, Ph.D.Co-Founder & Chief Scientific Officer\, Iktos \n\n\n\nAfter completing his post-doc fellowship at UCLA where Dr. Perron worked on the total synthesis of Brasillicardin A\, a complex natural molecule known for having a potent immunosuppressive activity\, he was a medicinal chemist in CNS indications at Laboratoires Servier. He later switched to data science and chemoinformatics at Quinten\, a company specialized in data science services. In 2016\, with his business partners Yann Gaston-Mathé and Nicolas Do Huu\, Dr. Perron co-founded Iktos\, a start-up company developing AI technologies for new drug design. \n\n\n\n\n\n\n\n\n\nFranck Le Vaillant\, Ph.D.\, MBASenior Scientist & Deputy Lab Head\, Iktos \n\n\n\nUpon completion of his Ph.D.\, Dr. Le Vaillant became a SNF-postdoctoral fellow to the Max-Planck-Institute für Kohlenforschung in Mülheim an der Ruhr where he developed Ni-catalyzed C-O bond formations using nitrous oxide. He later started the Labcom HitCat\, a joint lab between the company Seqens and the group of Prof. Géraldine Masson (CNRS). Dr. Le Vaillant joined Iktos in July 2022\, where he works on the installation\, development and utilization of the Iktos Robotics Platform for Drug Discovery. \n\n\n\n\n\n\n\n\nWe hope to see you on March 6\, 2024 for this FREE educational webinar. URL:https://bionj.org/event/integrating-ai-and-robotics-to-discover-new-drugs-faster/ LOCATION:New Jersey CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240208T164500 DTEND;TZID=America/New_York:20240208T213000 DTSTAMP:20260503T074135 CREATED:20231129T132752Z LAST-MODIFIED:20241120T151605Z UID:9813-1707410700-1707427800@bionj.org SUMMARY:2024 BioNJ Annual Dinner Meeting & Innovation Celebration DESCRIPTION:Thursday\, February 8\, 2024 | 4:45 p.m.-9:30 p.m. | Hilton East Brunswick\n\n\n\n\nBecome a Sponsor\n\n\n\nPhoto Gallery\n\n\n\n\nWe are excited to share that due to popular demand\, BioNJ’s 31st Annual Dinner Meeting and Innovation Celebration is sold out! Thank you to everyone who has registered to attend tomorrow’s celebration. We look forward to paying tribute to New Jersey’s extraordinary life sciences ecosystem and the Patients who inspire us. Registration is now closed and we are unable to accommodate walk-ins. We apologize for any inconvenience. Please contact BioNJ at 609-890-3185 with any questions. Thank you for your support and understanding. \n\n\n\n\n\n\n\nJoin us for BioNJ’s 31st Annual Dinner Meeting and Innovation Celebration\, taking place Thursday\, February 8\, 2024\, at the Hilton East Brunswick\, where we’ll celebrate the extraordinary innovation happening in the Garden State.   \n\n\n\nMany surprises are in store for an evening of inspiration and camaraderie. Kicking off the start of the New Year\, BioNJ’s Annual Dinner Meeting & Innovation Celebration features:  \n\n\n\n\nNetworking with biopharmaceutical professionals\, government officials\, academic leaders and professional service providers\n\n\n\nThe presentation of the Dr. Sol J. Barer Award for Vision\, Innovation and Leadership by Dr. Barer himself to William H. Lewis\, J.D.\, MBA\, Chair and CEO of Insmed\n\n\n\nAn inspirational Spoken Word by Lupus Warrior Shanelle Gabriel\n\n\n\nThe acclaimed Innovator Awards honoring New Jersey companies that received a new FDA drug approval in 2023\n\n\n\nThe presentation of the Heart of BioNJ Awards to Lisa Salberg\, Founder & CEO\, Hypertrophic Cardiomyopathy Association; Amadou Diarra\, Ph.D.\, Senior Vice President\, Global Policy\, Advocacy & Government Affairs\, Bristol Myers Squibb and Mark Peters\, Senior Director\, Patient Advocacy\, Genmab \n\n\n\nA special Keynote honoring Patients around the world\n\n\n\nA Cocktail Hour\, Dinner Program and Dessert Reception\n\n\n\n\nDon’t miss this memorable evening celebrating New Jersey’s life sciences ecosystem and the Patients who inspire us. Registration for BioNJ Members is $500 and $575 for Future Members. Reserve a table for your Team today.  \n\n\n\nThe 2024 Innovator Award Honorees Include: \n\n\n\n\n\n\nAbbVie \n\n\n\nAcrotech Biopharma \n\n\n\nAmicus Therapeutics \n\n\n\nAcadia Pharmaceuticals \n\n\n\nBausch + Lomb\n\n\n\nBristol Myers Squibb \n\n\n\nCorMedix Inc. \n\n\n\nDaiichi Sankyo \n\n\n\nEisai \n\n\n\nEli Lilly \n\n\n\nEvive Biotech \n\n\n\nGamida Cell\n\n\n\nGC Biopharma USA \n\n\n\nGenmab\n\n\n\nGSK \n\n\n\nIpsen\n\n\n\n\n\n\n\nIveric BIO\n\n\n\nJohnson & Johnson\n\n\n\nLexicon Pharmaceuticals\n\n\n\nMelinta Therapeutics \n\n\n\nNestlé Health Science \n\n\n\nNovartis\n\n\n\nNovo Nordisk \n\n\n\nOctapharma\n\n\n\nProtalix Biotherapeutics\n\n\n\nPfizer \n\n\n\nPharming \n\n\n\nRegeneron\n\n\n\nSanofi \n\n\n\nPlus\, Boehringer Ingelheim Animal Health USA and Zoetis for FDA Animal Drug Approvals\n\n\n\n\n\n\n\n\n\n\n\n\n\nContact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship Opportunities\, reserve a table and to place your organization in the spotlight.  URL:https://bionj.org/event/2024-annual-dinner-meeting-innovation-celebration/ LOCATION:Hilton East Brunswick\, 3 Tower Center Blvd\, East Brunswick\, NJ\, 08816\, United States CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240118T120000 DTEND;TZID=America/New_York:20240118T130000 DTSTAMP:20260503T074135 CREATED:20231212T181900Z LAST-MODIFIED:20231218T194037Z UID:9888-1705579200-1705582800@bionj.org SUMMARY:How End-User Adoption is Key to Software Deployment Success DESCRIPTION:FREE Webinar: How End-User Adoption is Key to Software Deployment Success \n\n\n\nThursday\, January 18\, 2024 | 12:00 p.m.-1:00 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin us for this intimate discussion with industry leaders on best practices to ensure end-user adoption in software project deployment. Topics to be covered include: \n\n\n\n\nUsing an MVP (Minimum Viable Product) strategy under the guidance of a seasoned business analyst to meet crucial end-user requirements.\n\n\n\nEmploying Agile methodology for continuous feedback and improvement.\n\n\n\nControlling scope and managing expectations through phased rollouts.\n\n\n\nReflecting on past challenges and successes.\n\n\n\n\nInvite your entire Project Team to attend this FREE webinar\, created for project managers\, business analysts\, engineering\, IT end-users\, operators\, scientists and more! \n\n\n\nSpeakers: \n\n\n\n\n\n\n\n\nAnthony DeJohnDirector\, Systems & Software SolutionsControl Associates \n\n\n\nMr. DeJohn boasts a successful 30-year career in process control\, digital manufacturing and process data analytics technologies\, establishing himself as a prominent process automation leader.  Passionate about manufacturing excellence\, digital tools\, and leveraging data from the shop floor to enterprise systems\, Mr. DeJohn remains at the forefront of innovation in the industry. \n\n\n\n\n\n\n\n\n\nPaula HudsonSenior Lab Systems ArchitectThermo Fisher Scientific \n\n\n\nMs. Hudson has accumulated over 20 plus years’ experience as a concept-to-launch project manager\, application designer\, data analyst\, database architect and application support expert. Through her work at universities and with one of the largest pharmaceutical manufacturers in the world\, she is recognized for her ability to guide impactful change.  \n\n\n\n\n\n\n\n\n\nSusanne BrownVice President\, Program ManagementInsmed \n\n\n\nMs. Brown works with a team of talented program managers to support and drive excellence in drug development bringing new promising medications to Patients.  After spending time in the microbiology lab and running clinical development programs\, she decided to dedicate her career in all avenues of project\, program\, resource and portfolio management. Prior to Insmed\, Ms. Brown held various roles at several large pharmaceutical and Healthcare companies \n\n\n\n\n\n\n\n\nWe hope to see you on January 18\, 2024 for this FREE educational webinar. URL:https://bionj.org/event/how-end-user-adoption-is-key-to-software-deployment-success/ LOCATION:New Jersey CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231207T120000 DTEND;TZID=America/New_York:20231207T130000 DTSTAMP:20260503T074135 CREATED:20231031T140557Z LAST-MODIFIED:20231115T153551Z UID:9584-1701950400-1701954000@bionj.org SUMMARY:BioNJ Health Equity in Clinical Trials Best Practices Webinar DESCRIPTION:BioNJ’s Health Equity in Clinical Trials Best Practices Webinar: Designing Trials to Broaden Reach and Expand Diversity\n\n\n\nThursday\, December 7\, 2023 | 12:00 p.m. – 1:00 p.m. | Free Webinar\n\n\n\n\nRegister Today!\n\n\n\nHealth Equity in Clinical Trials Best Practices Database\n\n\n\n\nBioNJ has been working passionately to increase health equity in clinical trials over the past 18 months. To that end\, we are pleased to announce the second webinar in BioNJ’s Health Equity in Clinical Trials Best Practices Webinar Series. Please join us on Thursday\, December 7\, from 12:00 p.m. to 1:00 p.m.\, as three industry experts share case studies on methods and techniques which their organizations use to “Broaden Reach and Expand Diversity in Clinical Trials.” \n\n\n\nPresenters include: \n\n\n\n\n\n\n\n\nMichel Reid\, Senior Director and Head\, Global Demographics & Diversity for GSK\, will present on My Living Legacy\, created in partnership with the Tigerlily Foundation to empower Black and other BIPOC people to more deeply understand and trust in clinical trials and to consider clinical trials as a possible treatment option for life-threatening diseases like breast cancer. Mr. Reid will also share how GSK partnered with MiOrato ensure that women from underserved communities are represented in clinical trials for Ovarian Cancer by training public health student in socioeconomically disadvantaged neighborhoods to become community health educators.  \n\n\n\n\n\n\n\n\n\nThe FDA defines a decentralized clinical trial as a clinical investigation where some or all of the trial-related activities occur at a location separate from the investigator’s location. Today’s technologies let Patients remotely engage with trial activities\, creating better Patient experiences and letting sponsors execute faster trials – driven by high-quality data. Kelly McKee\, Vice President\, Decentralized Clinical Trials\, for Medidata\, will present on how to use decentralized trialsto broaden reach and improve Patient\, site and sponsor experiences. Using a case study\, Ms. McKee will explore what decentralized clinical trials mean for all stakeholders\, including biopharmaceutical companies. \n\n\n\n\n\n\n\n\n\nSunanda Gaur\, M.D.\, Director of the Clinical Research Center at Rutgers Robert Wood Johnson Medical School\, will share valuable insights into Rutgers’ four-year study on the long-term and delayed impacts of COVID-19 in children. Encompassing more than 2\,000 participants\, across 14 sites\, Dr. Gaur will discuss Rutgers’ community-facing strategy\, including bi-lingual recruitment leads\, used for trial enrollment. Additionally\, Dr. Gaur will elaborate on the decentralize component of the trial to ensure inclusion of diverse populations.  \n\n\n\n\n\n\n\n\nRegister for FREE and join us for this very important conversation. Come ready to ask questions and share your own organization’s initiatives. It’s about coming together to make a difference and ensure that “No Patient is ever left behind“. URL:https://bionj.org/event/bionj-health-equity-in-clinical-trials-best-practices-webinar-2/ LOCATION:New Jersey CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231201T083000 DTEND;TZID=America/New_York:20231201T150000 DTSTAMP:20260503T074135 CREATED:20230717T182336Z LAST-MODIFIED:20231129T122115Z UID:7820-1701419400-1701442800@bionj.org SUMMARY:2023 Inspiring Women in STEM Conference DESCRIPTION:Empowering Brilliance & Resilience for Long-Term Success\n\n\n\nFriday\, December 1\, 2023 | Sanofi U.S.\, 55 Corporate Drive\, Bridgewater\, NJ \n\n\n\nJoin us for BioNJ’s Ninth Annual Inspiring Women in STEM Conference on Friday\, December 1\, 2023. The action-packed schedule features forward-thinking presentations\, informative panel discussions\, audience participation exercises and quality networking.  \n\n\n\nMore timely than ever\, attendees are sure to come away with valuable and actionable ideas and guidance! \n\n\n\n\n\n\n\n\nDon’t Miss This Special Keynote \n\n\n\nBe UNFORGETTABLE: How to Position Yourself for Success \n\n\n\nPresented by Alessandra Wall\, Ph.D.\, Executive Coach\, Speaker\, Founder\, Noteworthy \n\n\n\nImagine stepping into any situation and feeling 100% confident in your ability to articulate your value and the impact you can make for your team\, your company\, a client or a prospective employer. This keynote explores three fail-proof strategies to position yourself to do more of what you excel at and love. You will discover a process to confidently share your areas of excellence with others and help them understand the impact you can make for them and your organizations. You’ll develop a blueprint to speak up\, own your power and value and share it with others without guilt or unease ― and become UNFORGETTABLE! \n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\nClick here or contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities. Call (609) 890-3185 with any questions.   URL:https://bionj.org/event/2023-inspiring-women-in-stem-conference/ LOCATION:Sanofi\, Sanofi Building D\, Corporate Dr\, Bridgewater Township\, NJ\, 08807 CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/07/IWSTEM.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231116T083000 DTEND;TZID=America/New_York:20231116T141500 DTSTAMP:20260503T074135 CREATED:20230809T152945Z LAST-MODIFIED:20230918T163650Z UID:8176-1700123400-1700144100@bionj.org SUMMARY:2023 BioNJ Patient Advocacy Summit DESCRIPTION:Thursday\, November 16\, 2023\, 8:30 a.m.-2:15 p.m.\n\n\n\nBristol Myers Squibb • 3551 Lawrenceville Rd\, Princeton\, NJ 08540 \n\n\n\n\nRegister Today\n\n\n\nBecome a Sponsor\n\n\n\n\nIn its eighth year\, BioNJ’s Patient Advocacy Summit is taking place November 16 at Bristol Myers Squibb. With topics requested by the Patient advocacy community\, we hope you join us for this important conversation! Please check out the agenda below and click here to register. \n\n\n\nThe Summit will bring together Patients\, Patient Advocacy Groups\, Caregivers\, Clinicians and R&D Professionals for a day of Education\, Engagement and Empowerment. Attendees will gain valuable tools and insights\, share best practices and meet key stakeholders within the health care ecosystem.  \n\n\n\nJoin us for this dynamic and educational discussion that will leave us all inspired and armed with new tools to make a difference on behalf of Patients! \n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nA must attend program for anyone who advocates on behalf of Patients! Click here to register! Attendance is open and free to ALL Patient Advocacy Groups and R&D company Patient advocacy and government affairs professionals.  \n\n\n\nPlus\, if you are unable to attend in person\, and are interested in watching a live streamed version of the event\, please contact Randi Bromberg at RBromberg@BioNJ.org. URL:https://bionj.org/event/2023-bionj-patient-advocacy-summit/ LOCATION:Bristol Myers Squibb\, 3551 Lawrenceville Rd\, Princeton\, New Jersey\, 08540\, United States CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/BioNJ_PPA-Summit_Logo_copy-copy.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231101T130000 DTEND;TZID=America/New_York:20231101T180000 DTSTAMP:20260503T074135 CREATED:20230828T175346Z LAST-MODIFIED:20231003T201630Z UID:8643-1698843600-1698861600@bionj.org SUMMARY:2023 AI & Digital Health Day DESCRIPTION:Wednesday\, November 1\, 2023 • 1:00 p.m. – 6:00 p.m. \n\n\n\n340 Mt. Kemble Ave\, Morristown \n\n\n\n\nRegister Today\n\n\n\nBecome a Sponsor\n\n\n\n\nAI is rapidly changing the way we do things in the workplace\, and the impact in the life sciences industry has been both rapid and significant. BioNJ\, in partnership with Morgan Stanley\, will host its inaugural BioNJ AI & Digital Health Day on November 1. \n\n\n\nJoin us for this important program which will: \n\n\n\n\nHighlight emerging trends within the life sciences industry\n\n\n\nProvide access to investors\, thought leaders and experts for advice and guidance\n\n\n\nAddress some of the challenges that entrepreneurs face as they create innovative AI and digital health solutions to improve Patient outcomes\n\n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nSPACE IS LIMITED! Register today and join an audience of entrepreneurs and industry professionals that support the life sciences and digital health ecosystem for this timely and informative discussion. Registration is $25 for BioNJ Members and $35 for Future Members. Click here to register. Contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities. URL:https://bionj.org/event/2023-ai-digital-health-day/ LOCATION:Morgan Stanley\, 340 Mt. Kemble Ave.\, New Jersey\, 07960\, United States CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/AI-Digital-Health-Color-With-Sponsors-1.png END:VEVENT END:VCALENDAR